The ones that are most upset are those who bet too much, don't know enough about the workings of developing a new drug, let alone a platform, and are hurting financially. All because we were greedy and thought this would pay off sooner. (me)
So am I angry? No. Am I going to sell my shares today? No.
I would like things to move along faster but I don't need them to as much as the Rett kids. Anavex has helped a bunch of those kids already. What have I done today?
"But I am starting to think shorting biotechs with market caps under $2B should be illegal, and instead the SEC ought to step up enforcement of these companies to make sure they aren't misleading investors."
It should be based on revenue (i.e.)...no shorting on companies with less $10B in revenues.